Clinical Trial Update: Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3) [Phase 2]

View source ↗

Summary

Phase 2 OPTIMUS-3 study completed and results posted evaluating optimization of anti-platelet therapy in patients with diabetes and coronary artery disease, spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2010-02-12